Cassiopea Partners acted as sole financial advisor to White Bridge Investments and Biofarma Group (“Biofarma”) in the acquisition of a majority stake in International Health Science (“IHS” or the “Business Unit”), the finished products business division of Giellepi S.p.A. (“Giellepi”) and Italian leader in the development of nutraceutical dietary...
Cassiopea Partners advises White Bridge Investments and Biofarma Group in the acquisition of a majority stake in the Finished Products Division of Giellepi S.p.A., leader in the development of nutraceutical dietary supplements and medical devices
